During the past decade, GynCare MUDr. Michael Svec s.r.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GynCare MUDr. Michael Svec s.r.o." are "Endometriosis" (3 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "GynCare MUDr. Michael Svec s.r.o." in a lesser frequency.

Most popular intervention types in "GynCare MUDr. Michael Svec s.r.o." are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BAY1817080" (2 trials), "BAY1128688" (1 trials), "Elagolix" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "GynCare MUDr. Michael Svec s.r.o." are 3 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "GynCare MUDr. Michael Svec s.r.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in GynCare MUDr. Michael Svec s.r.o., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in GynCare MUDr. Michael Svec s.r.o., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".